{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:08:43Z","timestamp":1761581323123},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.cpet.2015.05.004","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T15:07:41Z","timestamp":1436022461000},"page":"487-494","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["PET\/Computed Tomography in the Individualization of Treatment of Prostate Cancer"],"prefix":"10.1016","volume":"10","author":[{"given":"Francesco","family":"Ceci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziano","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.cpet.2015.05.004_bib1","first-page":"i34","article-title":"ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of prostate cancer","volume":"16","author":"ESMO Guidelines Task Force","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cpet.2015.05.004_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"Guidelines on prostate cancer. Part 1: screening, diagnosis and local treatment with curative intent \u2013 update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.cpet.2015.05.004_bib3","first-page":"964","article-title":"Do impalpable (T1c) cancers visible on ultrasound differ from those not visible?","volume":"169","author":"Ohori","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cpet.2015.05.004_bib4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2214\/ajr.175.4.1751161","article-title":"Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings","volume":"175","author":"Cornud","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cpet.2015.05.004_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiol.2251011938","article-title":"Prostate: high-frequency Doppler US imaging for cancer detection","volume":"225","author":"Halpern","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.cpet.2015.05.004_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1148\/radiol.2392050949","article-title":"Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging","volume":"239","author":"Akin","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.cpet.2015.05.004_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.2291020200","article-title":"Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging","volume":"229","author":"Engelbrecht","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.cpet.2015.05.004_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1148\/radiol.2333032098","article-title":"Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging\u2014initial experience","volume":"233","author":"Buckley","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.cpet.2015.05.004_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1600-0455.2001.042001070.x","article-title":"Optimal timing of post-biopsy MR imaging of the prostate","volume":"42","author":"Ikonen","year":"2001","journal-title":"Acta Radiol"},{"key":"10.1016\/j.cpet.2015.05.004_bib10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2214\/ajr.183.4.1831079","article-title":"Organ confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging","volume":"183","author":"Qayyum","year":"2004","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.cpet.2015.05.004_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.rcl.2006.07.008","article-title":"MR imaging and MR spectroscopy in prostate cancer management","volume":"44","author":"Katz","year":"2006","journal-title":"Radiol Clin North Am"},{"issue":"6","key":"10.1016\/j.cpet.2015.05.004_bib12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2006.01.043","article-title":"Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy","volume":"49","author":"Briganti","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.cpet.2015.05.004_bib13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0090-4295(02)02526-8","article-title":"Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database","volume":"61","author":"Freedland","year":"2003","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.cpet.2015.05.004_bib14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","article-title":"EAU guidelines on prostate cancer. Part 2: treatment of advanced, relapsing and castration-resistant prostate cancer","volume":"65","author":"Hedenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.cpet.2015.05.004_bib15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/cncr.20093","article-title":"Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1\u2013T3 prostate carcinoma in the prostate specific antigen era: what should we expect?","volume":"100","author":"Khuntia","year":"2004","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2015.05.004_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.urology.2005.03.014","article-title":"Efficacy of prostatic fossa biopsy in detecting local recurrence after radical prostatectomy","volume":"66","author":"Naya","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.cpet.2015.05.004_bib17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.juro.2007.10.059","article-title":"A\u00a0model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy J","volume":"179","author":"Choueiri","year":"2008","journal-title":"Urol"},{"key":"10.1016\/j.cpet.2015.05.004_bib18","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","article-title":"Inaugural article: positron emission tomography provides molecular imaging of biological processes","volume":"97","author":"Phelps","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.cpet.2015.05.004_bib19","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.ejrad.2010.07.023","article-title":"Choline PET\/CT for prostate cancer: main clinical applications","volume":"80","author":"Fuccio","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cpet.2015.05.004_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.nu.01.070181.000523","article-title":"Dietary choline: biochemistry, physiology and pharmacology","volume":"1","author":"Zeisel","year":"1981","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.cpet.2015.05.004_bib21","first-page":"3599","article-title":"Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells","volume":"61","author":"Ackerstaff","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpet.2015.05.004_bib22","first-page":"1642","article-title":"Detection and localization of prostate cancer: correlation of (11)C-choline PET\/CT with histopathologic step-section analysis","volume":"46","author":"Farsad","year":"2005","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2015.05.004_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.113.123018","article-title":"Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET\/CT with pelvic multiparametric MR imaging with endorectal coil","volume":"55","author":"Kitajima","year":"2014","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2015.05.004_bib24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.eururo.2008.04.030","article-title":"(11)C-choline positron emission tomography\/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms","volume":"54","author":"Schiavina","year":"2008","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.cpet.2015.05.004_bib25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.eururo.2013.05.025","article-title":"Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature","volume":"64","author":"Punnen","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.cpet.2015.05.004_bib26","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.108.061507","article-title":"Influence of trigger PSA and PSA kinetics on 11C-choline PET\/CT detection rate in patients with biochemical relapse after radical prostatectomy","volume":"50","author":"Castellucci","year":"2009","journal-title":"J\u00a0Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2015.05.004_bib27","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.2967\/jnumed.114.138313","article-title":"Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-choline PET\/CT scan before salvage radiation therapy?","volume":"55","author":"Castellucci","year":"2014","journal-title":"J\u00a0Nucl Med"},{"issue":"12","key":"10.1016\/j.cpet.2015.05.004_bib28","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s00259-014-2872-x","article-title":"Impact of 11C-choline PET\/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial","volume":"41","author":"Ceci","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2015.05.004_bib29","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","article-title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study","volume":"11","author":"Bolla","year":"2010","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.cpet.2015.05.004_bib30","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","article-title":"Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy","volume":"25","author":"Stephenson","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2015.05.004_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.eururo.2011.10.010","article-title":"Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy","volume":"61","author":"Stephenson","year":"2012","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.cpet.2015.05.004_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.radonc.2011.05.005","article-title":"Influence of (11)C-choline PET\/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer","volume":"99","author":"Souvatzoglou","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cpet.2015.05.004_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1748-717X-6-44","article-title":"[18F]fluoroethylcholine-PET\/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET\/CT-positive lymph nodes","volume":"6","author":"W\u00fcrschmidt","year":"2011","journal-title":"Radiat Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2015.05.004_bib34","first-page":"1270","article-title":"11C-choline PET\/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients","volume":"41","author":"Picchio","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2015.05.004_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2014.05.050","article-title":"18F-choline positron emission tomography\/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients","volume":"90","author":"D'Angelillo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 6","key":"10.1016\/j.cpet.2015.05.004_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1464-410X.2012.11216.x","article-title":"Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy","volume":"109","author":"Schulman","year":"2012","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.cpet.2015.05.004_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clgc.2012.08.003","article-title":"Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy","volume":"11","author":"Berkovic","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.cpet.2015.05.004_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.eururo.2013.09.024","article-title":"The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer","volume":"65","author":"Pond","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.cpet.2015.05.004_bib39","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.eururo.2006.10.045","article-title":"The natural history of noncastrate metastatic prostate cancer after radical prostatectomy","volume":"51","author":"Yossepowitch","year":"2007","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.cpet.2015.05.004_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000144059","article-title":"[11C]Choline PET\/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study","volume":"81","author":"Rinnab","year":"2008","journal-title":"Urol Int"},{"issue":"5","key":"10.1016\/j.cpet.2015.05.004_bib41","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2011.07.060","article-title":"Pelvic\/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography\/computed tomography","volume":"60","author":"Rigatti","year":"2011","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.cpet.2015.05.004_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.eururo.2014.02.011","article-title":"Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years","volume":"67","author":"Suardi","year":"2015","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.cpet.2015.05.004_bib43","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.eururo.2012.08.003","article-title":"18F-fluoroethylcholine PET\/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent","volume":"63","author":"Tilki","year":"2013","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.cpet.2015.05.004_bib44","doi-asserted-by":"crossref","first-page":"38.e9","DOI":"10.1016\/j.urolonc.2013.03.006","article-title":"Utility of [11C]choline PET\/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series","volume":"32","author":"Passoni","year":"2014","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.cpet.2015.05.004_bib45","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00259-012-2083-2","article-title":"Clinical impact of 18F-choline PET\/CT in patients with recurrent prostate cancer","volume":"39","author":"Soyka","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859815000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859815000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:55:14Z","timestamp":1537491314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859815000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1556859815000516"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2015.05.004","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET\/Computed Tomography in the Individualization of Treatment of Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2015.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}